TABLE 5.
Patient subgroup | No. of patients | % CD3+ CD16/56+ cells producing TNF-α |
---|---|---|
HIV−, no LNE, survived | 10 | 25.1 |
HIV+, no LNE, survived | 14 | 23.3 |
HIV+, LNE, survived | 14 | 5.3 |
HIV+, LNE, deceased | 10 | 3.8 |
HIV+, no LNE, deceased | 1 | 0 |
Patient subgroup | No. of patients | % CD3+ CD16/56+ cells producing TNF-α |
---|---|---|
HIV−, no LNE, survived | 10 | 25.1 |
HIV+, no LNE, survived | 14 | 23.3 |
HIV+, LNE, survived | 14 | 5.3 |
HIV+, LNE, deceased | 10 | 3.8 |
HIV+, no LNE, deceased | 1 | 0 |